Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP858775.RAfKbyE6EhzjvS9G0EEs4_AiX1Mi-TiOb4WhcH_kXCYYc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP858775.RAfKbyE6EhzjvS9G0EEs4_AiX1Mi-TiOb4WhcH_kXCYYc130_assertion type Assertion NP858775.RAfKbyE6EhzjvS9G0EEs4_AiX1Mi-TiOb4WhcH_kXCYYc130_head.
- NP858775.RAfKbyE6EhzjvS9G0EEs4_AiX1Mi-TiOb4WhcH_kXCYYc130_assertion description "[Thus, miR-137 and RTVP-1 are attractive therapeutic targets for the eradication of GSCs and for the treatment of GBM.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP858775.RAfKbyE6EhzjvS9G0EEs4_AiX1Mi-TiOb4WhcH_kXCYYc130_provenance.
- NP858775.RAfKbyE6EhzjvS9G0EEs4_AiX1Mi-TiOb4WhcH_kXCYYc130_assertion evidence source_evidence_literature NP858775.RAfKbyE6EhzjvS9G0EEs4_AiX1Mi-TiOb4WhcH_kXCYYc130_provenance.
- NP858775.RAfKbyE6EhzjvS9G0EEs4_AiX1Mi-TiOb4WhcH_kXCYYc130_assertion SIO_000772 23714687 NP858775.RAfKbyE6EhzjvS9G0EEs4_AiX1Mi-TiOb4WhcH_kXCYYc130_provenance.
- NP858775.RAfKbyE6EhzjvS9G0EEs4_AiX1Mi-TiOb4WhcH_kXCYYc130_assertion wasDerivedFrom befree-20150227 NP858775.RAfKbyE6EhzjvS9G0EEs4_AiX1Mi-TiOb4WhcH_kXCYYc130_provenance.
- NP858775.RAfKbyE6EhzjvS9G0EEs4_AiX1Mi-TiOb4WhcH_kXCYYc130_assertion wasGeneratedBy ECO_0000203 NP858775.RAfKbyE6EhzjvS9G0EEs4_AiX1Mi-TiOb4WhcH_kXCYYc130_provenance.